Optas LLC Has $2.06 Million Holdings in UnitedHealth Group Incorporated (NYSE:UNH)

Optas LLC cut its stake in UnitedHealth Group Incorporated (NYSE:UNH) by 7.1% in the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 4,157 shares of the healthcare conglomerate’s stock after selling 317 shares during the period. Optas LLC’s holdings in UnitedHealth Group were worth $2,056,000 as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Richelieu Gestion SA acquired a new position in shares of UnitedHealth Group during the 4th quarter worth about $26,000. CGC Financial Services LLC raised its holdings in shares of UnitedHealth Group by 1,000.0% in the 4th quarter. CGC Financial Services LLC now owns 55 shares of the healthcare conglomerate’s stock valued at $29,000 after purchasing an additional 50 shares during the period. True Wealth Design LLC bought a new stake in shares of UnitedHealth Group in the 4th quarter valued at about $31,000. LFA Lugano Financial Advisors SA raised its holdings in shares of UnitedHealth Group by 148.1% in the 4th quarter. LFA Lugano Financial Advisors SA now owns 67 shares of the healthcare conglomerate’s stock valued at $35,000 after purchasing an additional 40 shares during the period. Finally, Transcendent Capital Group LLC bought a new stake in shares of UnitedHealth Group in the 4th quarter valued at about $40,000. 87.86% of the stock is owned by institutional investors and hedge funds.

UnitedHealth Group Stock Performance

NYSE UNH opened at $509.26 on Monday. The company has a current ratio of 0.85, a quick ratio of 0.85 and a debt-to-equity ratio of 0.69. The firm has a market capitalization of $468.72 billion, a price-to-earnings ratio of 31.13, a P/E/G ratio of 1.48 and a beta of 0.60. The firm’s 50 day simple moving average is $498.34 and its 200 day simple moving average is $501.63. UnitedHealth Group Incorporated has a 1 year low of $436.38 and a 1 year high of $554.70.

UnitedHealth Group (NYSE:UNH) last issued its earnings results on Tuesday, April 16th. The healthcare conglomerate reported $6.91 earnings per share for the quarter, beating analysts’ consensus estimates of $6.63 by $0.28. UnitedHealth Group had a net margin of 4.05% and a return on equity of 26.50%. The firm had revenue of $99.80 billion for the quarter, compared to analyst estimates of $99.23 billion. During the same quarter last year, the business posted $6.26 earnings per share. The company’s quarterly revenue was up 8.6% on a year-over-year basis. As a group, research analysts expect that UnitedHealth Group Incorporated will post 27.55 earnings per share for the current fiscal year.

UnitedHealth Group Increases Dividend

The business also recently announced a quarterly dividend, which was paid on Tuesday, June 25th. Shareholders of record on Monday, June 17th were given a $2.10 dividend. The ex-dividend date of this dividend was Monday, June 17th. This represents a $8.40 dividend on an annualized basis and a yield of 1.65%. This is a positive change from UnitedHealth Group’s previous quarterly dividend of $1.88. UnitedHealth Group’s dividend payout ratio (DPR) is currently 51.34%.

Analysts Set New Price Targets

UNH has been the topic of a number of research analyst reports. HSBC raised shares of UnitedHealth Group from a “hold” rating to a “buy” rating and set a $580.00 target price on the stock in a report on Wednesday, June 5th. Cantor Fitzgerald reissued an “overweight” rating and issued a $591.00 price target on shares of UnitedHealth Group in a report on Wednesday, June 12th. Truist Financial reissued a “buy” rating and issued a $600.00 price target on shares of UnitedHealth Group in a report on Wednesday, April 17th. Morgan Stanley lowered their price target on shares of UnitedHealth Group from $618.00 to $584.00 and set an “overweight” rating on the stock in a report on Friday, April 5th. Finally, Robert W. Baird assumed coverage on shares of UnitedHealth Group in a report on Thursday, May 30th. They issued an “outperform” rating and a $597.00 price target on the stock. Three research analysts have rated the stock with a hold rating, seventeen have given a buy rating and one has given a strong buy rating to the stock. According to data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $579.74.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.